Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:
“Honored to have presented our work on hypertrophic synovium in severe haemophilia A during the moderated poster session at the WFH 2026 World Congress in Kuala Lumpur.
It was a real privilege to be among the candidates for the Christine Lee Young Researcher Award for best poster and to share this moment with such talented young researchers from around the world.
Our study, RESOLVE, focused on changes in hypertrophic synovium in adult patients with severe haemophilia A receiving emicizumab prophylaxis.
The data suggest that while emicizumab provides excellent bleed control, meaningful improvement in synovial status can also be observed, reinforcing the importance of joint monitoring and individualized joint health management.
Grateful for this opportunity, for the scientific exchange, and for the chance to contribute to ongoing research in haemophilia care.”

Find more posts featuring Ilenia Calcaterra on Hemostasis Today.
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A